AI-driven quality control: When can algorithms replace checks?

Introduction

Quality control in pharmaceutical production is critical, but also resource-intensive. Every tablet must be inspected, every batch verified, every deviation investigated. Can AI take over some of this work? And if so, when is it safe and regulatory acceptable?

At Hyperbolic, we have implemented AI-driven quality control for several pharmaceutical companies. Our experience is clear: AI can be extremely effective, but there are limits to what it can and should do.

Where AI Excels in Quality Control

Visual Inspection of Products

Computer vision AI is excellent at detecting visual defects in pharmaceutical products.

Typical Use Cases:

• Tablet Inspection: Cracks, chips, discoloration, deformation

• Packaging Inspection: Label accuracy, sealing integrity, tamper-evidence

• Fill Level Verification: Correct volume in vials and blister packs

• Print Quality: Batch numbers, expiry dates correct and readable

Advantages over Manual Inspection:

• Consistency: AI does not get tired or distracted

• Speed: Can inspect 100x faster than humans

• Objectivity: No subjective variation between inspectors

• Documentation: Automatic logging and image documentation of all findings

Case: We implemented a tablet inspection system for a generics manufacturer. The system inspects 500,000 tablets/day with 99.8% accuracy. It detects defects that humans often overlook.

Process Monitoring and Anomaly Detection

AI can monitor production parameters in real-time and detect deviations before they become problems.

Use Cases:

• Fermentation Monitoring: Detects abnormal trends in pH, temperature, oxygen

• Coating Uniformity: Analyzes coating thickness data to identify problems early

• Sterilization Cycles: Verifies that all parameters are within spec

• Environmental Monitoring: Flags unexpected trends in particle counts or temperature

Benefits:

• Proactive vs Reactive: Catch problems before they affect product quality

• Complex Patterns: AI sees patterns that humans would miss

• 24/7 Monitoring: Never an inattentive moment

Data Review and Trend Analysis

AI can automate parts of the time-consuming data review process.

Use Cases:

• Batch Record Review: Automatically checks that all data points are within spec

• Stability Data Analysis: Identify trends indicating potential shelf-life issues

• OOS Investigation Support: Analyze historical data to identify root cause patterns

Where Humans are Still Essential

Complex Deviation Assessment

When something goes wrong, investigations often require:

• Understanding of context and history

• Creative problem-solving

• Risk assessment and impact evaluation

• Cross-functional collaboration

AI can assist with data analysis, but humans must drive the investigation.

Edge Cases and Unique Situations

AI is trained on patterns. Completely new, unseen problems require human judgment.

Example: An unexpected reaction between new packaging material and API. AI would not recognize this as a problem since it has never been seen before.

Regulatory and Ethical Accountability

A person must be accountable for quality decisions. AI can inform, but not decide.

Risk Assessment

Decisions such as "Is this deviation critical?" require nuanced risk evaluation that AI cannot match.

Framework: When Can AI Replace Checks?

We use this decision framework at Hyperbolic:

AI Can Replace When:

1. The Task is Well-defined with clear pass/fail criteria

2. Large Data Volumes make manual review impractical

3. Objective Measurement is possible (not subjective assessment)

4. High Repeatability - the same input should give the same assessment

5. Consequence of Error is Low or there is human backup

Humans Must Retain Control When:

1. Complex Assessment is Required

2. Context and Experience are Critical

3. Novel Situations May Arise

4. Regulatory Accountability is Required

5. High Consequence of Failure

The Hybrid Model: The Best of Both Worlds

In practice, hybrid models work best:

AI Screens, Humans Decide:

• AI inspects all tablets, flags potential defects

• Human inspector reviews only flagged items

• Result: 95% reduction in human inspection time, higher catch rate

AI Suggests, Humans Approve:

• AI analyzes batch records and suggests "release" or "investigate"

• QA reviews AI's rationale and makes final decision

• Result: Faster reviews with preserved checks and balances

Validation and Regulatory Compliance

AI in quality control is often GAMP Category 5 (configured software) with direct GxP impact. It requires:

Computer System Validation:

• Installation Qualification (IQ)

• Operational Qualification (OQ)

• Performance Qualification (PQ)

Key Validation Challenges:

Performance Qualification: How well does AI need to perform to be acceptable?

Our Approach: Define clear metrics:

• Sensitivity: % of defects AI finds (must be ≥99%)

• Specificity: % of good products AI accepts (must be ≥98%)

• False Positive Rate: How many good products are incorrectly rejected?

Test on a minimum of 10,000 diverse samples including known defects.

Change Control: When the AI model is updated, is revalidation required?

Our Approach:

• Minor updates (e.g., re-training on more data): Abbreviated testing

• Major changes (new architecture): Full revalidation

• Document all changes in the validation lifecycle

Ongoing Verification: How is it ensured that AI continues to perform?

Our Approach:

• Periodic Sampling: Human review of x% of AI decisions

• Performance Monitoring: Track sensitivity/specificity continuously

• Annual Review: Comprehensive performance review

Practical Implementation Challenges

Challenge 1: Integration with Existing Systems

AI must integrate with:

• Manufacturing Execution Systems (MES)

• Quality Management Systems (QMS)

• Equipment (cameras, sensors, etc.)

Solution: Design with integration in mind from the start. Budget time for connectivity and data flow setup.

Challenge 2: Training Data

Good AI requires a lot of annotated data. But defective products are (fortunately) rare.

Solution:

• Collect data over time before AI implementation

• Use simulated defects for training

• Transfer learning from other, similar products

Challenge 3: Operator Acceptance

QC staff may be skeptical or concerned about job security.

Solution:

• Involve operators from the start

• Train them to be AI supervisors

• Communicate that AI is about augmentation, not replacement

• Show concretely how their work becomes less monotonous and more value-adding

Case: End-to-End AI Quality System

Client: Large-scale sterile injectable manufacturer

Challenge: Manual inspection of 2 million vials/month. 15 inspectors, high turnover, varying performance.

Solution:

• Phase 1: AI visual inspection (cracks, particulates, fill volume)

• Phase 2: AI process monitoring (sterilization, filling parameters)

• Phase 3: AI-assisted batch disposition

Implementation:

• 9 months validation including parallel run with manual inspection

• Training of 30,000 images (10% defective)

• Integration with existing MES and QMS

• Comprehensive operator training program

Results After 12 Months:

• Defect Detection Rate: 99.7% (vs 97.2% manual)

• False Positive Rate: 1.8% (acceptable for human review)

• Inspection Throughput: +300%

• Inspector Time: Reduced by 80%, redeployed to investigation and improvement work

• Zero Regulatory Issues through two audits

Future Trends

Real-Time Release Testing: FDA's PAT (Process Analytical Technology) initiative opens the door for real-time quality decisions based on process data. AI will be a key enabler.

Predictive Quality: Not just detect defects, but predict them before they arise based on process trends.

Autonomous Quality Systems: Further down the line, fully autonomous quality systems that decide on release without human intervention. But this requires significant regulatory evolution.

Conclusion

AI can significantly improve quality control in pharma: higher accuracy, better consistency, lower costs. But it is not a simple swap of humans with algorithms.

The success criteria are:

1. Clear Use Cases where AI's strengths match the task

2. Robust Validation that meets GxP requirements

3. Hybrid Models that combine AI efficiency with human judgment

4. Change Management that ensures operator buy-in

At Hyperbolic, we guide pharmaceutical companies throughout the entire journey, from use case selection through validation to go-live and beyond.

Contact us to discuss how AI can transform your quality control.